Arch Therapeutics (OTCMKTS:ARTH) Share Price Passes Below 50 Day Moving Average – Time to Sell?

Arch Therapeutics, Inc. (OTCMKTS:ARTHGet Free Report)’s stock price passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.18 and traded as low as $0.00. Arch Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.

Arch Therapeutics Price Performance

The company’s fifty day simple moving average is $0.18 and its 200 day simple moving average is $0.21.

About Arch Therapeutics

(Get Free Report)

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.

See Also

Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.